Louisiana 2014 Regular Session

Louisiana Senate Bill SR41

Introduced
4/7/14  

Caption

Commends D. Neil Granger, PhD, and his research team upon receipt of clinical designation as a new Center for Cardiovascular Disease and Sciences at LSU Health Sciences Center Shreveport.

Impact

The establishment of this center is poised to enhance the capabilities of LSU Health Sciences Center Shreveport, positioning it as a leading institution in cardiovascular specialties. With Louisiana's high rates of heart disease and related conditions, the center aims to provide cutting-edge treatment options and improve healthcare outcomes for local patients. This advancement may lead to better access to advanced medical care and foster further medical research, ultimately benefiting the state's public health landscape.

Summary

Senate Resolution 41, sponsored by Senator Peacock, commends Dr. D. Neil Granger and his research team at the Louisiana State University Health Sciences Center Shreveport for being awarded the clinical designation as a new Center for Cardiovascular Disease and Sciences by the Louisiana Board of Regents. This recognition highlights the significant contributions of Dr. Granger and his multidisciplinary team in the field of cardiovascular medicine and their commitment to advancing patient care through research and clinical excellence.

Sentiment

The sentiment surrounding SR41 is overwhelmingly positive, as it serves to recognize and celebrate the achievements of Dr. Granger and his team. The resolution reflects a shared appreciation for the hard work and dedication of healthcare professionals in improving cardiovascular health, which resonates with both lawmakers and the community. This collective recognition underscores the importance of investing in medical research and healthcare innovations in Louisiana.

Contention

While there are no notable points of contention directly related to the resolution, the context within which it is presented emphasizes the ongoing challenges of public health in Louisiana, particularly concerning cardiovascular diseases. The acknowledgment of the center's establishment implicitly raises awareness about the necessity of supporting healthcare initiatives to combat high mortality rates and improve health outcomes in regions facing significant public health challenges.

Companion Bills

No companion bills found.

Previously Filed As

LA SR43

Commends Dr. A. Wayne Orr, Director of the Center of Excellence for Cardiovascular Diseases and Sciences at LSU Health Sciences Center-Shreveport, for his extraordinary impact on cardiovascular disease.

LA HCR31

Commends D. Neil Granger, Ph.D., for his many accomplishments and contributions to the LSU Health Sciences Center in Shreveport

LA HCR64

Commends Dr. Andrew Chesson, Jr., dean of the School of Medicine at LSU Health Sciences Center Shreveport, upon his retirement

LA HR50

Commends Dr. Anil Nanda for his service to LSU Health Sciences Center-Shreveport

LA HR70

Commends Dr. Christopher Kevil of LSU Health Sciences Center at Shreveport on being awarded a Centers for Biomedical Research Excellence grant from the National Institutes of Health

LA HCR33

Commends Dr. G. E. Ghali for his leadership as chancellor of LSU Health Sciences Center in Shreveport

LA SR53

Commends the LSU Health Sciences Centers in Shreveport and in New Orleans on their contributions to healthcare development in Louisiana.

LA HCR23

Commend Louisiana State University Health Sciences Center at Shreveport for its extraordinary response to the COVID-19 pandemic

LA HR60

Commends the Comprehensive Alcohol Research Center at the LSU Health Sciences Center in New Orleans

LA SCR23

Expresses condolences upon the death of John McDonald, MD, chancellor emeritus of the LSU Health Sciences Center at Shreveport and dean emeritus of the School of Medicine in Shreveport.

Similar Bills

CA ACR67

Atherosclerotic cardiovascular disease (ASCVD).

NJ AJR59

Designates November of each year as "Diabetes and Cardiovascular Disease Awareness Month."

NJ SJR42

Designates November of each year as "Diabetes and Cardiovascular Disease Awareness Month."

NJ AJR118

Designates November of each year as "Diabetes and Cardiovascular Disease Awareness Month."

CA ACR66

Diabetes and Cardiovascular Disease Awareness Month.

MI HR0018

A resolution to declare February 2025 as American Heart Month and February 5, 2025, as National Wear Red Day in the state of Michigan.

MI SR0007

A resolution to recognize February 2023 as American Heart Month and February 3, 2023, as “National Wear Red Day”.

MI SR0068

A resolution to recognize September 2023 as Cholesterol Education Month and September 1, 2023, as Low-Density Lipoprotein Cholesterol (LDL-C) Awareness Day.